The sum of receptor discordance that is, the addition of conversion of the ER‐status from ER‐positive to ER‐negative and vice versa as well as changes from PR‐positive to PR‐negative and vice versa are clinically of limited value, due to the heterogeneity of the cancers involved. The gene discussed is ESR1; the disease is cancer.